Archive.fm

Squawk on the Street

Cramer's Morning Take: Abbott Labs 4/17/24

Jim and Jeff discuss why this healthcare holding is being mismarked by the market. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
CNBC Investing Club Disclaimer

Duration:
4m
Broadcast on:
17 Apr 2024
Audio Format:
mp3

Jim and Jeff discuss why this healthcare holding is being mismarked by the market. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

What's on the horizon for financial markets? At PJIM, it's a question that over 1,400 investment professionals relentlessly research in pursuit of your long-term goals. Specialised across asset classes, but united in collaboration, our teams provide global and local expertise. Our investments shape tomorrow, today. Pursue your tomorrow with PJIM, a leading global asset manager. Jim Kramer here to share with you a sample of my take on the market from today's CBC Investing Club morning meeting. It is quite obvious to me that there are people who care only about that we're not going to get the rating cost. And that has not been my rap. My rap business is that their companies are doing well regardless, and that's what you buy, and that's what we have to talk about. Yeah, absolutely, you know, Pal said yesterday afternoon, maybe kind of throughout the idea that, you know, three cuts baseline no more, maybe it's none, we'll see. But I think your focus on companies is well served. I mean, you had a good reaction to Morgan Stanley yesterday that's following through today. We can talk more about that in a minute. Our oversold, so we have done some buys the last couple of days. Right, the last couple of days. Right, because that's what we do, that's the discipline. And it's a sign that the oscillator, that stocks have come down to a good level really fast. Right, we've had a nice three, four percent pull back in the S&P. So you look for some things to buy, did some Kotari yesterday. Right. Consolation brands, a little bit more best buy. Right, and look, remember what we do. As stocks went up, and you can know, you can look at all of them, whether it be a Lindy, or whether it be Caterpillar, whether it be Disney. As they go up, we do some selling, we trim. So we're ready and have the cash when it goes down. Otherwise, here's what would happen. You'd be scrambling to sell right now into maybe you would be selling something a brook on instead of being able to buy it. That's the essence of what we teach. Remember, this is a teaching product, which brings me to Abbott Labs. Okay, so Abbott Labs is very much like GE Healthcare in the 60s. Okay, I say that, and I speak to Abbott many times. Abbott is a gas that the stocks down because they raise forecast. They don't raise forecast. No. So this is a mistake. Tomorrow there'll be a lot of people who come out and say that they raise the price target. This is an opportunity I didn't mention on Squawk. I believe that it comes down more. We will buy more. Sure, buying some this morning. So it was top and bottom line beat. They'd be by three cents. Organic sales up 10.85th consecutive quarter of double digit organic growth. Remember, that excludes COVID sales too. They're not going to get credit for anything COVID related. Join the CNBC Investing Club with Jim Kramer to catch my member exclusive warning meetings every day at 1020 a.m. Visit cmbc.com/morningtake to become a member today. That's one word, morning take. All opinions expressed by Jim Kramer on this podcast and in connection with the CNBC Investing Club are solely Kramer's opinions and do not reflect the opinions of CNBC, NBC, Universal, or their parent company or affiliates and may have been previously disseminated by Kramer on television, radio, internet or another medium. No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Kramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment or strategy. You should be aware of the risk of loss in following any strategy or investment discussed in the content from Kramer. If you view the full CNBC Investing Club disclaimer, please visit cmbc.com/investingclubdisclaimer. You seek the key, but first, you must learn the ways of precision, craft and performance with Acura's all-electric ZDX, with a premium bang and all-of-son sound system up to a 313-mile range and a Type S variant with an estimated 500 horsepower, the ZDX is their most powerful SUV yet. Unlock the energy when you visit Acura.com to order yours today. [BLANK_AUDIO]